# The Conventional and Alternative Therapeutic Approaches in Arterial Stiffness Management

**Authors:** Joseph Iharinjaka Randriamboavonjy, Valeria Conti, Ines Mazza, Thierry Ragot, Charles Andrianjara, Herintsoa Rafatro, Angela Tesse

PMC · DOI: 10.3390/pharmaceutics18020166 · 2026-01-27

## TL;DR

This review compares physical exercise, drugs, and medicinal plants in managing arterial stiffness, highlighting the potential of plant-based treatments.

## Contribution

The paper systematically evaluates the effects of medicinal plants on arterial stiffness, identifying 18 species with potential therapeutic benefits.

## Key findings

- Physical exercise reduces blood glucose and blood pressure, preventing arterial stiffness.
- Eighteen medicinal plant species show potential in reducing vascular stiffness parameters like Pulse Wave Velocity.
- Plant extracts improve vascular function by enhancing nitric oxide production and inhibiting aortic inflammation.

## Abstract

Arterial stiffness encompasses the global structural and functional modifications that induce progressively increased vascular rigidity, whether associated with pathological cardiovascular or metabolic alterations or not. This narrative review highlights the comparative effects of physical exercise practices, current drug treatments, and approaches based on the use of medicinal plants on arterial stiffness, due to metabolic and/or blood pressure disorders. This review would provide up-to-date information for further experimental and clinical studies concerning the prevention/therapy of high glucose levels and vascular remodelling. Indeed, it is known that physical activities can reduce high blood glucose and blood pressure, allowing the prevention of arterial stiffness. Concerning conventional drugs, some are used to treat arterial stiffness, but their effectiveness is generally limited to treating components of the disease. Eighteen medicinal plant species, belonging to fourteen different botanical families, have potential activities against arterial stiffness in preclinical and/or clinical studies. Several plant extracts reduced the parameters implicated in vascular stiffness, such as the Pulse Wave Velocity, the Augmentation Index, and the Cardio–Ankle Vascular Index. Some plant extracts reduced arterial stiffness by primarily lowering glycemia and/or blood pressure in animal models, which has also been confirmed in humans. By reducing arterial stiffness, plant extracts or derived bioactive compounds not only improved vascular relaxation by enhancing Nitric Oxide production and/or antioxidant defences, but also inhibited inflammation-induced aortic remodelling and promoted elastin neo-synthesis. Polyphenols have often been identified as the main effective compounds involved in these beneficial effects. However, only a few studies explained the mechanisms associated.

## Linked entities

- **Chemicals:** Nitric Oxide (PubChem CID 145068)

## Full-text entities

- **Genes:** Ncf1 (neutrophil cytosolic factor 1) [NCBI Gene 114553] {aka Ncf-1, p47phox}, Loxl1 (lysyl oxidase-like 1) [NCBI Gene 315714], Il1b (interleukin 1 beta) [NCBI Gene 24494] {aka IL-1F2}, Rhoa (ras homolog family member A) [NCBI Gene 117273] {aka Arha, Arha2}, Sod2 (superoxide dismutase 2) [NCBI Gene 24787] {aka MnSOD}, Tnf (tumor necrosis factor) [NCBI Gene 24835] {aka RATTNF, TNF-alpha, Tnfa}, Crp (C-reactive protein) [NCBI Gene 25419] {aka Aa1249, Ab1-341, Ab2-196, Ac1-114, Ac1262, Ac2-069}, Sirt1 (sirtuin 1) [NCBI Gene 309757] {aka Sir2}, Nos2 (nitric oxide synthase 2) [NCBI Gene 24599] {aka Nos2a, iNos}, BBS2 (Bardet-Biedl syndrome 2) [NCBI Gene 583] {aka BBS, RP74}, Pik3cg (phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma) [NCBI Gene 298947] {aka Pi3k}, Gcg (glucagon) [NCBI Gene 24952] {aka GLP-1, Glp1, Glp2}, GLP1R (glucagon like peptide 1 receptor) [NCBI Gene 2740] {aka GLP-1, GLP-1-R, GLP-1R}, Renbp (renin binding protein) [NCBI Gene 81759], Cat (catalase) [NCBI Gene 24248] {aka CS1, Cas1, Cat01, Catl, Cs-1}, Irs1 (insulin receptor substrate 1) [NCBI Gene 25467] {aka IRS1IRM}, Slc5a2 (solute carrier family 5 member 2) [NCBI Gene 64522] {aka Sglt2}, AGER (advanced glycosylation end-product specific receptor) [NCBI Gene 177] {aka RAGE, SCARJ1, sRAGE}, CCL2 (C-C motif chemokine ligand 2) [NCBI Gene 6347] {aka GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1}, EDN1 (endothelin 1) [NCBI Gene 1906] {aka ARCND3, ET1, HDLCQ7, PPET1, QME}, Vcam1 (vascular cell adhesion molecule 1) [NCBI Gene 25361] {aka VCAM1B}, LPL (lipoprotein lipase) [NCBI Gene 4023] {aka HDLCQ11, LIPD}, Arg1 (arginase 1) [NCBI Gene 29221], Eln (elastin) [NCBI Gene 25043] {aka RATTREL11, TREL11, Trela, Trela26}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 59086] {aka Tgfb}, Nox1 (NADPH oxidase 1) [NCBI Gene 114243], CA6 (carbonic anhydrase 6) [NCBI Gene 765] {aka CA-VI, GUSTIN}, REN (renin) [NCBI Gene 5972] {aka ADTKD4, HNFJ2, RTD}, Rac1 (Rac family small GTPase 1) [NCBI Gene 363875], Sod1 (superoxide dismutase 1) [NCBI Gene 24786] {aka CuZnSOD}, IL18 (interleukin 18) [NCBI Gene 3606] {aka IGIF, IL-18, IL-1g, IL1F4}, Il6 (interleukin 6) [NCBI Gene 24498] {aka ILg6, Ifnb2}, Ccn2 (cellular communication network factor 2) [NCBI Gene 64032] {aka CTGRP, Ctgf}, Rb1 (RB transcriptional corepressor 1) [NCBI Gene 24708], Slc2a4 (solute carrier family 2 member 4) [NCBI Gene 25139] {aka Glut4}, Agt (angiotensinogen) [NCBI Gene 24179] {aka ANRT, Ang, AngII, PAT}, HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase) [NCBI Gene 3156] {aka LDLCQ3, LGMDR28, MYPLG}, ELN (elastin) [NCBI Gene 2006] {aka ADCL1, SVAS, WBS, WS}, Tnfrsf11b (TNF receptor superfamily member 11B) [NCBI Gene 25341] {aka Opg}, Nox4 (NADPH oxidase 4) [NCBI Gene 85431], Mmp9 (matrix metallopeptidase 9) [NCBI Gene 81687], ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, Cybb (cytochrome b-245 beta chain) [NCBI Gene 66021] {aka Gp91-phox, Nox2}, AGT (angiotensinogen) [NCBI Gene 183] {aka ANHU, SERPINA8, hFLT1}, DPP4 (dipeptidyl peptidase 4) [NCBI Gene 1803] {aka ADABP, ADCP2, CD26, DPPIV, TP103}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, Prkaa2 (protein kinase AMP-activated catalytic subunit alpha 2) [NCBI Gene 78975] {aka Ampk, Ampka2}, IL2 (interleukin 2) [NCBI Gene 3558] {aka IL-2, TCGF, lymphokine}, Mmp2 (matrix metallopeptidase 2) [NCBI Gene 81686], AP2B1 (adaptor related protein complex 2 subunit beta 1) [NCBI Gene 163] {aka ADTB2, AP105B, AP2-BETA, CLAPB1}, RENBP (renin binding protein) [NCBI Gene 5973] {aka RBP, RNBP}, Pparg (peroxisome proliferator-activated receptor gamma) [NCBI Gene 25664] {aka PPARgamma2}, Prkaca (protein kinase cAMP-activated catalytic subunit alpha) [NCBI Gene 25636] {aka Cs-PKA, PKCA1}, PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468] {aka CIMT1, FPLD3, GLM1, NR1C3, PPARG1, PPARG2}, Nos3 (nitric oxide synthase 3) [NCBI Gene 24600] {aka eNos}, Cyp7a1 (cytochrome P450 family 7 subfamily A member 1) [NCBI Gene 25428] {aka CHAP, CYP7, CYP7S1}, NOS3 (nitric oxide synthase 3) [NCBI Gene 4846] {aka EC-NOS, ECNOS, MYMY8, NOSIII, cNOS, eNOS}, Cyba (cytochrome b-245 alpha chain) [NCBI Gene 79129] {aka Phox, p22-phox}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}
- **Diseases:** skin disorders (MESH:D012871), coronary heart disease (MESH:D003327), injury to (MESH:D014947), degenerative disease (MESH:D019636), headache (MESH:D006261), Inflammation (MESH:D007249), aortic damage (MESH:D001018), arterial diseases (MESH:D002539), arterial fibrosis (MESH:D005355), cardiometabolic diseases (MESH:D024821), flatulence (MESH:D005414), abdominal pain (MESH:D015746), CKD (MESH:D051436), arteriosclerosis (MESH:D001161), renal failure (MESH:D051437), Diabetes (MESH:D003920), endothelial dysfunction (MESH:D014652), resistant (MESH:D060467), stable angina (MESH:D060050), cancer (MESH:D009369), calcification of (MESH:D002114), diabetes vascular complications (MESH:D003925), diarrhoea (MESH:D003967), stroke (MESH:D020521), essential hypertension (MESH:D000075222), blood vessel dysfunction (MESH:D009383), dengue fever (MESH:D003715), gestational diabetes (MESH:D016640), obese (MESH:D009765), common (MESH:D020326), coronary artery stenosis (MESH:D023921), systemic lupus erythematosus (MESH:D008180), vomiting (MESH:D014839), hypotension (MESH:D007022), metabolic diseases (MESH:D008659), ovarian polycystic syndrome (MESH:D011085), Hypertension (MESH:D006973), blood sugar (MESH:D006402), arteriosclerotic (MESH:D015140), AS (MESH:C566112), death (MESH:D003643), arterial hypertension (MESH:D000081029), back pain (MESH:D001416), Atherosclerosis (MESH:D050197), arterial calcification (MESH:D061205), thrombosis (MESH:D013927), cough (MESH:D003371), damage to arterial function (MESH:D000071079), vascular dysfunction (MESH:D002561), vascular (MESH:D057772), hypercholesterolemic (MESH:D006938), weight loss (MESH:D015431), insulin resistance (MESH:D007333), myocardial infarction (MESH:D009203), uremic toxins (MESH:D006463), arterial remodelling (MESH:D066253), arterial dysfunction (MESH:D012078), infections (MESH:D007239), cardiovascular complications (MESH:D002318), hypertrophy (MESH:D006984)
- **Chemicals:** sugar (MESH:D000073893), salt (MESH:D012492), zinc (MESH:D015032), Emblicanin-A (MESH:C467022), gallic acid (MESH:D005707), linagliptin (MESH:D000069476), RA (MESH:C041376), carbachol (MESH:D002217), Fat (MESH:D005223), ginsenoside (MESH:D036145), efonidipine (MESH:C066425), nebivolol (MESH:D000068577), Green Tea extract (MESH:C045651), cyclic Guanosine Monophosphate (MESH:D006152), NaCl (MESH:D012965), TAG (MESH:D014280), telmisartan (MESH:D000077333), aldosterone (MESH:D000450), carbon (MESH:D002244), aliskiren (MESH:C446481), rutin (MESH:D012431), fosinopril (MESH:D017328), clitorin (MESH:C077190), alpha-mangostin (MESH:C021053), polysaccharides (MESH:D011134), losartan (MESH:D019808), Protocatechuic aldehyde (MESH:C005581), Quercetin (MESH:D011794), Eleutheroside B (MESH:C028305), atenolol (MESH:D001262), nitrotyrosine (MESH:C002744), arachidonic acid (MESH:D016718), glycogen (MESH:D006003), biguanides (MESH:D001645), sulfonylureas (MESH:D013453), empagliflozin (MESH:C570240), catechins (MESH:D002392), ACh (MESH:D000109), STZ (MESH:D013311), xanthones (MESH:D044004), Salvianolic acid B (MESH:C076944), water (MESH:D014867), phenol (MESH:D019800), AGEs (MESH:D017127), tyrosine (MESH:D014443), MF (MESH:D008687), Danshensu (MESH:C035055), free radicals (MESH:D005609), kaempferol (MESH:C006552), xanthine (MESH:D019820), ethanol (MESH:D000431), 8-hydroxy-2'-deoxyguanosine (MESH:D000080242), cholesterol (MESH:D002784), NO (MESH:D009569), dihydropyridine (MESH:C038806), blood glucose (MESH:D001786), irbesartan (MESH:D000077405), lacidipine (MESH:C060285), drinking water (MESH:D060766), Emblicanin-B (MESH:C467023)
- **Species:** fungal sp. M-D (species) [taxon 1074441], Malus domestica (apple, species) [taxon 3750], Selenicereus undatus (dragon fruit, species) [taxon 176265], Watermelon [taxon 260674], Achillea millefolium (species) [taxon 13329], Labisia pumila var. alata (varietas) [taxon 1381587], Fennel [taxon 48038], Garcinia mangostana (mangosteen, species) [taxon 58228], Mus musculus (house mouse, species) [taxon 10090], Panax (genus) [taxon 4053], Citrullus lanatus (watermelon, species) [taxon 3654], Panax ginseng (Asiatic ginseng, species) [taxon 4054], Carica papaya (mamon, species) [taxon 3649], Allium sativum (garlic, species) [taxon 4682], Labisia pumila (species) [taxon 396393], Melissa officinalis (common balm, species) [taxon 39338], Moringa oleifera (horseradish tree, species) [taxon 3735], Emblica officinalis (amla, species) [taxon 296036], Centella asiatica (Asiatic pennywort, species) [taxon 48106], Phaleria macrocarpa (species) [taxon 223762], Homo sapiens (human, species) [taxon 9606], Panax quinquefolius (American ginseng, species) [taxon 44588], Rattus norvegicus (brown rat, species) [taxon 10116], Bos taurus (bovine, species) [taxon 9913], Curcuma longa (turmeric, species) [taxon 136217], Eleutherococcus senticosus (species) [taxon 82096], Camellia sinensis (black tea, species) [taxon 4442], Salvia miltiorrhiza (Chinese salvia, species) [taxon 226208], Anethum graveolens (dill, species) [taxon 40922]
- **Mutations:** lysine at position 34 instead of arginine
- **Cell lines:** C57BL/6N — Mus musculus (Mouse), Embryonic stem cell (CVCL_2H81), Muscle — Rattus norvegicus (Rat), Finite cell line (CVCL_XB60), VSMC — Homo sapiens (Human), Finite cell line (CVCL_4009)

## Figures

20 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12944209/full.md

---
Source: https://tomesphere.com/paper/PMC12944209